Type of Deal Value Acquirer Target Adviser to acquirer (tax) Adviser to target (tax) Acquisition $8.6 billion Perrigo Company Elan Pharmaceuticals Sullivan & Cromwell - Andrew Mason, Davis Wang, Ron Creamer / Dillon Eustace A&L Goodbody / Cadwalader Wickersham & Taft Merger $7.6 billion Health Management Associates Community Health Systems Weil, Gotshal & Manges - Helyn Goldstein Kirkland & Ellis Acquisition $3.4 billion Essilor International Transitions Optical (PPG Industries) Jones Day Wachtell, Lipton, Rosen & Katz - Jodi Schwartz / Hogan Lovells Acquisition $2.9 billion Hudson’s Bay Company Saks Incorporated Stikeman Elliott - Dean Kraus / Willkie Farr & Gallagher Wachtell, Lipton, Rosen & Katz - Jodi Schwartz Acquisition $1.25 billion CITIC Securities Company CLSA Sullivan & Cromwell Acquisition $535 million Cubist Pharmaceuticals Optimer Pharmaceuticals Ropes & Gray Sullivan & Cromwell Acquisition $357 million Mitsubishi Tanabe Pharmaceutical Medicago Stikeman Elliott - Franco Gadoury, Dominic Bédard-Lapointe / Ropes & Gray McCarthy Tétrault Acquisition Undisclosed Actelion Ceptaris Therapeutics Covington & Burling Type of Deal Value Issuer/Borrower Lead managers/arrangers Adviser to issuer/borrower (tax) Adviser to lead managers (tax) Notes Offering $2 billion Royal Bank of Canada RBC Capital Markets / Goldman Sachs Sullivan & Cromwell / Norton Rose Fulbright Canada Davis Polk & Wardwell - Harry Ballan Notes Offering $1.7 billion PepsiCo Goldman Sachs / Merrill Lynch / Morgan Stanley Davis Polk & Wardwell - Avishai Shachar Jones Day Initial Public Offering $412.8 million Graña y Montero Credit Suisse / JP Morgan / Morgan Stanley / Banco BTG Pactual Simpson Thacher and Bartlett / Muñiz, Ramírez, Pérez-Taiman & Olaya Abogados Davis Polk & Wardwell - Po Sit Initial Public Offering $398 million SPH REIT Credit Suisse / DBS Bank / OCBC Bank Shook Lin & Bok WongPartnership / Sidley Austin Bond Issue $265.1 million TAG Immobilien Credit Suisse / Close Brothers Seydler Bank Noerr - Michaela Engel Initial Public Offering $122 million Agios Pharmaceuticals JP Morgan / Goldman Sachs Wilmer Cutler Pickering Hale and Dorr Davis Polk & Wardwell - Michael Mollerus
August 05 2013